Search Results 321-330 of 16472 for immunothérapie vitiligo effets secondaires psychiatriques

  1. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  2. Mayo Clinic

    Final days of 5X Challenge! 5X My Gift! The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology. 5X My Gift!

  3. Non-Hodgkin's Lymphoma Clinical Trials - Mayo Clinic Research

    The goal of this study is to evaluate a new approach to immunotherapy in NHL by combining two antibodies, veltuzumab and epratuzumab. For treatment ...

  4. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  5. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  6. Thyroid cancer in children - Mayo Clinic

    Siobhan T. Pittock, M.B., B.Ch., Pediatric Endocrinology, Mayo Clinic: Hello, I'm Siobhan Pittock, pediatric endocrinologist at Mayo Clinic Children's ...

  7. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  8. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  9. Clinical trials - Oncology (Medical)

    ... immunotherapy, or chemoimmunotherapy. Brain Tumor Repository. Scottsdale/Phoenix, Ariz. The main objective of the Brain Tumor Repository is to allow access ...

  10. Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas - Mayo Clinic

    Giving pembrolizumab alone or with idelalisib or ibrutinib may be an effective treatment in patients with chronic lymphocytic leukemia or other low-grade B-cell ...